Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Finance Home
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,884.50
-48.67
(-0.41%)
NZD/USD
0.6261
-0.0004
(-0.06%)
NZD/EUR
0.5768
+0.0031
(+0.54%)
ALL ORDS
7,373.30
+60.90
(+0.83%)
ASX 200
7,177.80
+55.50
(+0.78%)
OIL
75.70
+1.33
(+1.79%)
Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5900
-0.0800
(-4.79%)
At close: 04:00PM EDT
1.6300
+0.04
(+2.52%)
After hours:
07:55PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
75,475
75,475
78,447
227,547
148,364
Cost of revenue
26,967
26,967
14,217
2,392
-
Gross profit
48,508
48,508
64,230
225,155
-
Operating expenses
Research development
118,927
118,927
105,975
146,936
175,611
Selling general and administrative
109,082
109,082
184,985
199,615
65,854
Total operating expenses
228,009
228,009
290,960
346,551
241,465
Operating income or loss
-179,501
-179,501
-226,730
-121,396
-93,101
Interest expense
56,810
56,810
46,353
22,670
8,120
Total other income/expenses net
2,652
2,652
3,975
515
4,056
Income before tax
-233,659
-233,659
-269,108
-143,551
-97,165
Income from continuing operations
-233,659
-233,659
-269,108
-143,551
-97,165
Net income
-233,659
-233,659
-269,108
-143,551
-97,165
Net income available to common shareholders
-233,659
-233,659
-269,108
-143,551
-97,165
Basic EPS
-
-3.52
-9.31
-5.23
-3.59
Diluted EPS
-
-3.52
-9.31
-5.23
-3.59
Basic average shares
-
66,407
28,903
27,474
27,090
Diluted average shares
-
66,407
28,903
27,474
27,090
EBITDA
-
-176,349
-222,143
-120,334
-88,726
© 2023 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About our ads